NEW YORK, Nov. 26, 2013 /PRNewswire/ -- Dr. Brian Mehling, New York-based orthopedic surgeon and founder of Blue Horizon International, spoke Sunday in Shangdong, China at the 2013 Taishan Academic Forum International Conference on Hematopoietic Stem Cells and Leukemia.
Over 200 Chinese doctors and graduate students also attended the Taishan Academic Forum 2013 International Conference, sponsored by the Weifang Medical University in Shangdong. They discussed the use of stem cell treatments for chronic conditions and acute diseases, and how such treatments have changed the face of global health care, allopathic medicines and traditional Chinese medicines.
"Stem cell treatments are without a doubt the future of medicine," stated Dr. Mehling. "It is very important that young doctors learn about the possibilities in stem cell research, and also about the treatments that are already available for patients with different chronic conditions.
Blue Horizon International is a health care consulting company which combines cutting edge medical treatment and research with philanthropy. BHI provides resources and services to children and adults of all backgrounds, but especially those who are medically underserved. BHI subsidiaries have successfully performed over 2000 documented stem cell procedures on over 500 patients to date. For more information please visit Blue Horizon International at www.bluehorizoninternational.com.
PRLog ID: www.prlog.org/12247276
|SOURCE Blue Horizon International|
Copyright©2012 PR Newswire.
All rights reserved